The p53 and mdm‐2 genes in human testicular germ‐cell tumors

Molecular Carcinogenesis

Volumn 12, Issue 3, 1995, Pages 124-131

  Riou, Guy ^a   Barrois, Michel ^a   Prost, Sandrine ^a   Terrier, Marie Josée ^a   Theodore, Christine ^b   Levine, Arnold J ^a  

^a PRINCETON UNIVERSITY   (United States)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

mdm 2; p53; testicular germ cell tumors

Indexed keywords

PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; SEMINOMA; TESTIS TUMOR; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; GENE AMPLIFICATION; GENES, P53; GERMINOMA; HUMAN; MALE; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; SEMINOMA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TESTICULAR NEOPLASMS;

EID: 0028936623     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.2940120303     Document Type: Article

References (33)

1. The role of the p53 tumor suppressor gene in tumorigenesis
2. The p53 tumor suppressor gene
3. Clinical implications of the p53 tumor‐suppressor gene
4. Wild‐type p53 activates transcription in vitro
5. Oncogenic forms of p53 inhibit p53‐regulated gene expression
6. A mutant p53 protein is required for the maintenance of the transformed cell phenotype in p53 plus ras transformed cells
7. Participation of p53 protein in the cellular response to DNA damage
8. p53‐dependent apoptosis modulates the cytotoxicity of anticancer agents
9. Cellular localization and cell cycle regulation by a temperature sensitive p53 protein
10. Braking the cycle
11. P53 is required for radiation induced apoptosis in mouse thymocytes
12. Altered cell cycle arrest and gene amplification potential accompany loss of wild‐type p53
13. No germline TP3 mutations detected in familial and bilateral testicular cancers
14. Mutations of the p53 gene do not occur in testis cancer
15. Absence of p53 gene mutations in primary neuroblastomas
16. p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia
17. Infrequent mutations in the p53 gene in primary human T‐cell acute lymphoblastic leukemia
18. Alterations of the p53 gene in Epstein‐Barr virus‐associated immunodeficiency‐related lymphomas
19. Characterization of a 54K dalton cellular SV40 tumor antigen in SV40 transformed cells
20. The amino acid sequence of murine p53 determined from a cDNA clone
21. Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny
22. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53
23. Molecular abnormalities of mdm‐2 and p53 genes in adult soft tissue sarcomas
24. Amplification of a gene encoding a p53‐associated protein in human sarcomas
25. The mdm‐2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation
26. Isolation and characterization of a human p53 cDNA clone: Expression of the human p53 gene
27. Rapid and sensitive detection of joint mutations of DNA polymorphisms using the polymerase chain reaction
28. p53 protein alterations in human testicuar cancer including pre‐invasive intratubular germ‐cell neoplasia
29. Clinical and genetic features of human germ cell cancer
30. Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors
31. Identification of an amplified, highly expressed gene in a human glioma
32. The p53‐mdm‐2 autoregulatory feedback loop